BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19079342)

  • 1. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition.
    Lee JY; Kang MB; Jang SH; Qian T; Kim HJ; Kim CH; Kim Y; Kong G
    Oncogene; 2009 Feb; 28(6):824-31. PubMed ID: 19079342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis.
    Chung JH; Eng C
    Cancer Res; 2005 Sep; 65(18):8096-100. PubMed ID: 16166282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
    Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
    Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Akt signalling in non-seminomatous testicular germ cell tumors.
    Hennenlotter J; Amend B; Vogel U; Renninger M; Springer C; Kuehs U; Stenzl A; Bedke J
    Anticancer Res; 2011 Nov; 31(11):3783-8. PubMed ID: 22110200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
    Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
    J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of Akt-induced keratinocyte transformation.
    Segrelles C; Moral M; Lara MF; Ruiz S; Santos M; Leis H; García-Escudero R; Martínez-Cruz AB; Martínez-Palacio J; Hernández P; Ballestín C; Paramio JM
    Oncogene; 2006 Feb; 25(8):1174-85. PubMed ID: 16247457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
    van Duijn PW; Trapman J
    Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
    Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
    Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.
    Lee JY; Jang KS; Shin DH; Oh MY; Kim HJ; Kim Y; Kong G
    Cancer Res; 2008 Jun; 68(11):4201-9. PubMed ID: 18519679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
    Vaish V; Sanyal SN
    Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN/Akt-p27(kip1) Signaling Promote the BM-MSCs Senescence and Apoptosis in SLE Patients.
    Tan W; Gu Z; Shen B; Jiang J; Meng Y; Da Z; Liu H; Tao T; Cheng C
    J Cell Biochem; 2015 Aug; 116(8):1583-94. PubMed ID: 25649549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Phosphatase and Tensin Homologue on Chromosome 10 on Angiotensin II-Mediated Proliferation, Collagen Synthesis, and Akt/P27 Signaling in Neonatal Rat Cardiac Fibroblasts.
    Nie L; Zhao JH; Wang J; Song R; Zhu SJ
    Biomed Res Int; 2016; 2016():2860516. PubMed ID: 27747225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
    Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S
    Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed proliferation of human osteoblasts.
    Li CJ; Chang JK; Chou CH; Wang GJ; Ho ML
    Biochem Pharmacol; 2010 Mar; 79(6):926-37. PubMed ID: 19883628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
    Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
    Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.